Kenya AIDS Vaccine Initiative HIV Vaccine Peer Leaders Training Manual
dc.contributor.author | Wakasiaka, Sabina | |
dc.contributor.author | Bwayo, JJ | |
dc.contributor.author | Ndinya-Achola, JO | |
dc.contributor.author | Omosa, Gloria | |
dc.contributor.author | Jaoko, Walter | |
dc.contributor.author | Waruingi, Wambui | |
dc.contributor.author | Ogutu, Hilda | |
dc.date.accessioned | 2013-04-04T06:25:31Z | |
dc.date.available | 2013-04-04T06:25:31Z | |
dc.date.issued | 2004 | |
dc.identifier.citation | Kenya AIDS Vaccine Initiative HIV Vaccine Peer Leaders Training Manual | en |
dc.identifier.uri | http://hdl.handle.net/11295/15247 | |
dc.description.abstract | MRC Human Immunology Unit, University of Oxford, Oxford, UK. The IFN-y enzyme-linked immunospot (ELI-Spot) assay is often used to map HIV-specific CD8 T-cell responses. We compared overlapping 15-mer pools with optimized CD8 epitopes to screen ELISpot responses in HIV-infected individuals. The 15-mer pools detected responses to previously undefined epitopes, but often missed low-level responses to predefined epitopes, particularly when the epitope was central in the 15-mer, rather than at the N-terminus or C-terminus. These factors should be considered in the monitoring of HIV vaccine trials. | en |
dc.language.iso | en | en |
dc.title | Kenya AIDS Vaccine Initiative HIV Vaccine Peer Leaders Training Manual | en |
dc.type | Other | en |
local.publisher | KAVI Dept. of Medical Microbiology | en |
Files in this item
Files | Size | Format | View |
---|---|---|---|
There are no files associated with this item. |